Cleared Traditional

K113129 - SPECTRALIS ANTERIOR SEGMENT MODULE (SPECTRALIS ASM) (FDA 510(k) Clearance)

Nov 2011
Decision
15d
Days
Class 2
Risk

K113129 is an FDA 510(k) clearance for the SPECTRALIS ANTERIOR SEGMENT MODULE (SPECTRALIS ASM). This device is classified as a Tomography, Optical Coherence (Class II - Special Controls, product code OBO).

Submitted by Heidelberg Engineering GmbH (Heidelberg, DE). The FDA issued a Cleared decision on November 8, 2011, 15 days after receiving the submission on October 24, 2011.

This device falls under the Ophthalmic FDA review panel. Regulated under 21 CFR 886.1570. Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases..

Submission Details

510(k) Number K113129 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 24, 2011
Decision Date November 08, 2011
Days to Decision 15 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF

Device Classification

Product Code OBO - Tomography, Optical Coherence
Device Class Class II - Special Controls
CFR Regulation 21 CFR 886.1570
Definition Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases.